Search clinical trials for: Agrippal

Total 18 results

Tel-Aviv Sourasky Medical Center

Unknown

Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Israel
Korea University Guro Hospital

Completed

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

Chronic Kidney Disease | Influenza | End Stage Renal Failure
University of Surrey

Completed

Training Study to Characterize Biomarkers to Flu Vaccines

Healthy

United Kingdom
SK Chemicals Co., Ltd.

Completed

Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

Prevention of Influenza

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers

Influenza
SK Chemicals Co., Ltd.

Completed

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Influenza, Human
SK Chemicals Co., Ltd.

Completed

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

Influenza, Human
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Influenza

Korea, Republic of
Crucell Holland BV

Completed

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

Influenza

China
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Influenza, Human
Korea University Guro Hospital

Completed

Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects

Human Influenza
NPO Petrovax

Completed

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Vaccine Reaction | Influenza | Influenza, Human | Influenza A | Acute Respiratory Infection | Influenza Type B | Flu | Influenza A H3N2 | Influenza A H1N1 | Flu, Human | Influenza Epidemic

Russian Federation
NPO Petrovax

Completed

Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Inactivated Subunit Influenza Vaccine Grippol® Quadri and Trivalent Inactivated Polymer-Subunit Vaccine Grippol® Plus in Volunteers

Influenza

Russian Federation
Novartis
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.

Human Influenza

Brazil
University of Oxford

Completed

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Influenza

United Kingdom
University Hospitals, Leicester
Novartis; Public Health England; Centers for Disease Control and Prevention

Completed

Heterosubtypic Immune Responses to Influenza in Older People

Influenza

United Kingdom
Novartis

Completed

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Relapsing Multiple Sclerosis

Belgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
Novartis
Novartis Vaccines

Completed

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Influenza, Human

Finland, Italy, Germany

3

Subscribe